You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

All You're Itching to Know About Atopic Dermatitis

  • Authors: Lawrence F. Eichenfield, MD; Jonathan I. Silverberg, MD, PhD, MPH; Emma Guttman-Yassky, MD, PhD; Eric L. Simpson, MD, MCR
  • CME / CE Released: 6/14/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/14/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, allergists/clinical immunologists, pediatricians, primary care physicians (PCPs), physician assistants (PAs), nurse practitioners (NPs), and nurses involved in the care of patients with atopic dermatitis (AD).

The goal of this activity is to present and discuss the most current evidence and practices in treating AD.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data on new/emerging topical AD medications 
    • Clinical effect of investigational targeted systemic/biologic agents for AD 
  • Have greater competence related to
    • Integrating into practice treatments that target the inflammatory etiology of AD 
    • Selecting age-appropriate treatment based on AD severity 
    • Tailoring evidence-based AD therapies based on patient characteristics 


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Lawrence F. Eichenfield, MD

    Professor of Dermatology and Pediatrics
    Vice Chair
    Department of Dermatology
    Chief
    Pediatric and Adolescent Dermatology
    University of California, San Diego
    Rady Children's Hospital, San Diego
    San Diego, California

    Disclosures

    Disclosure: Lawrence F. Eichenfield, MD, has disclosed the following relevant financial relationships:  
    Served as an advisor or consultant for: Amgen Inc.; Almirall; Dermavant; Dermira Inc.; Eli Lilly and Company; Forte Biosciences; Galderma Laboratories, L.P.; Incyte Corporation; LEO Pharma; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme  
    Served as a speaker or a member of a speakers bureau for: Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi Genzyme  
    Received grants for clinical research from: AbbVie Inc.; Regeneron Pharmaceuticals, Inc.; Ortho Dermatologics; Sanofi Genzyme  
    Owns stock, stock options, or bonds from: Forte Biosciences  
    Other: Asana Biosciences, LLC; Glenmark 

  • Jonathan I. Silverberg, MD, PhD, MPH

    Associate Professor
    Department of Dermatology
    Director
    Clinical Research
    Director
    Patch Testing
    The George Washington University School
    of Medicine and Health Sciences
    Washington, DC

    Disclosures

    Disclosure: Jonathan I. Silverberg, MD, PhD, MPH, has disclosed the following relevant financial relationships:  
    Served as an advisor or consultant for: AbbVie Inc.; AFYX; Arena Pharmaceuticals, Inc.; Asana Biosciences, LLC; BioMX; Bluefin; Bodewell; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Dermavant; Dermira Inc.; Eli Lilly and Company; Galderma Laboratories, L.P.; GlaxoSmithKline; Incyte Corporation; Kiniksa; LEO Pharma; Luna; Menlo; Novartis Pharmaceuticals Corporation; Pfizer Inc.; RAPT Therapeutics; Regeneron Pharmaceuticals, Inc; Sanofi  
    Served as a speaker or a member of a speakers bureau for: Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi  
    Received grants for clinical research from: Galderma Laboratories, L.P.; Pfizer Inc.  

  • Emma Guttman-Yassky, MD, PhD

    Waldman Professor and System Chair, Dermatology
    Icahn School of Medicine at Mount Sinai Medical Center
    New York, New York
    President
    International Eczema Council
    Chicago, Illinois

    Disclosures

    Disclosure: Emma Guttman-Yassky, MD, PhD, has disclosed the following relevant financial relationships:  
    Served as an advisor or consultant for: AbbVie Inc.; Aditum Bio; Almirall; Amgen Inc.; Asana Biosciences, LLC;  AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Cara Therapeutics; Celgene Corporation; Concert; DBV; Dermira Inc.; DS Biopharma; Eli Lilly and Company; EMD Serono; Escalier; Galderma Laboratories, L.P.; Ichnos Sciences; Incyte Kyowa Kirin; LEO Pharma; Mitsubishi Tanabe; Pandion Therapeutics; Pfizer Inc.; RAPT Therapeutics; Regeneron Pharmaceuticals, Inc.; Sanofi; Sienna Biopharma; Target PharmaSolutions; Union Therapeutics 
    Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Almirall; Amgen Inc.; AnaptysBio; Asana Biosciences, LLC; Boehringer-Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Dermavant; DS Biopharma; Eli Lilly and Company; Galderma Laboratories, L.P.; Ichnos Sciences; Innovaderm; Janssen Pharmaceuticals; Kiniksa; Kyowa Kirin; LEO Pharma; Novan; Pfizer Inc.; Ralexar; Regeneron Pharmaceuticals, Inc.; Sienna Biopharma; UCB Pharma, Inc.; Union Therapeutics 

  • Eric L. Simpson, MD, MCR

    Professor of Dermatology
    Oregon Health & Science University
    Portland, Oregon

    Disclosures

    Disclosure: Eric L. Simpson, MD, MCR, has disclosed the following relevant financial relationships:  
    Served as an advisor or consultant for: AbbVie Inc.; Arena Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Collective Acumen LLC; Eli Lilly and Company; Forte Bio; Incyte Corporation; Janssen Pharmaceuticals; Kyowa Hakko Kirin; LEO Pharma; Novartis Pharmaceuticals Corporation; Ortho Dermatologics; Pfizer Inc.; Pierre Fabre Dermo Cosmetique; Regeneron Pharmaceuticals, Inc.; Roivant; Sanofi; Valeant Pharmaceuticals International  
    Received grants for clinical research from: AbbVie Inc.; Eli Lilly and Company; Kyowa Hakko Kirin; LEO Pharma; Merck; Novartis Pharmaceuticals Corporation; Pfizer Inc; Regeneron Pharmaceuticals, Inc.; Sanofi; Tioga; Vanda  

Editor

  • Marinella Calle, PhD, CMPP

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Marinella Calle, PhD, CMPP, has disclosed no relevant financial relationships.

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

All You're Itching to Know About Atopic Dermatitis

Authors: Lawrence F. Eichenfield, MD; Jonathan I. Silverberg, MD, PhD, MPH; Emma Guttman-Yassky, MD, PhD; Eric L. Simpson, MD, MCRFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 6/14/2021

Valid for credit through: 6/14/2022

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

The Evolving Pathogenesis of Atopic Dermatitis

Learn about the pathogenesis of atopic dermatitis.
Emma Guttman-Yassky, MD, PhD

Current Concepts in Targeted Oral and Topical Therapies for Atopic Dermatitis

Learn about latest developments with targeted oral and topical therapies in atopic dermatitis.
Jonathan I. Silverberg, MD, PhD, MPH

Biologics for Atopic Dermatitis: New and Emerging Agents

Join the expert faculty as he covers hot topics with biologics in atopic dermatitis.
Eric L. Simpson, MD, MCR

Pediatric Atopic Dermatitis: Infants and Beyond

Join the faculty update on treatments for pediatric patients with atopic dermatitis.
Lawrence F. Eichenfield, MD
 

Assessment Survey

Before you begin, please take this brief survey.

  • Print